AKT inhibitors are a class of drugs designed to block the activity of the AKT kinase, a crucial component of the PI3K/AKT/mTOR pathway. This pathway is often hyperactivated in various types of cancer, leading to uncontrolled cell growth, survival, and proliferation. By inhibiting AKT, these drugs aim to disrupt these cancer-promoting signals.
